| Non-Muscle Invasive Bladder Urothelial Carcinoma studied in …STUDIED_INderived15 of 15show fewer |
|---|
| → studied in | NCT06770582Phase 2 · recruiting Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial · condition mapped ONTOLOGY_EXACT · 15 trials mapped (11 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06503614Phase 2 · recruiting A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 15 trials mapped (11 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04164082Phase 2 · active not recruiting Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 15 trials mapped (11 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05483868Phase 1 · active not recruiting A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer · condition mapped ONTOLOGY_EXACT · 15 trials mapped (11 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05521698Phase 1 · recruiting A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 15 trials mapped (11 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07302230NA · recruiting Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial · condition mapped CURATED_BROADER · 15 trials mapped (11 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05962541Phase 4 · recruiting Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs) · condition mapped ONTOLOGY_EXACT · 15 trials mapped (11 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06396533recruiting Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE) · condition mapped ONTOLOGY_EXACT · 15 trials mapped (11 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07064863Phase 1/Phase 2 · not yet recruiting A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC. · condition mapped ONTOLOGY_EXACT · 15 trials mapped (11 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06766266Phase 1 · recruiting Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment · condition mapped ONTOLOGY_EXACT · 15 trials mapped (11 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04496219Phase 2 · completed Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer · condition mapped ALIAS · 15 trials mapped (11 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06167356recruiting Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. · condition mapped ONTOLOGY_EXACT · 15 trials mapped (11 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06020807completed Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer · condition mapped ONTOLOGY_EXACT · 15 trials mapped (11 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05946369completed Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 15 trials mapped (11 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04730232Phase 2 · unknown Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable · condition mapped ONTOLOGY_EXACT · 15 trials mapped (11 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |